News Lilly to sell generic Humalog insulin at half price Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
